Literature DB >> 30013258

Changes in antioxidant status associated with haemodialysis in chronic kidney disease.

Adeyemi Ogunleye1, Akinwumi A Akinbodewa2, Oluseyi A Adejumo2, Tosin T Oluwafemi3, Damilola A Akinfaderin2.   

Abstract

Oxidative stress has been implicated in the pathogenesis, progression of chronic kidney disease (CKD) and development of cardiovascular complications. Hemodialysis (HD) has also been described to contribute significantly to oxidative stress in CKD patients, though reports are conflicting.
OBJECTIVE: We evaluated the effects of one session of HD on the antioxidant capacity and lipid peroxidation in CKD patients.
METHOD: Thirty-six CKD patients requiring HD were recruited into this study. Participants were naïve to HD and each completed a session of three hours using polysulfone membrane dialyzers. Blood samples were collected before and after dialysis. Total antioxidant capacity (TAC) was measured by ferric reducing antioxidant power (FRAP) while malondialdehyde (MDA) was measured using thiobarbituric acid-reactive substance (TBARS). Comparison was made between pre-HD and post-HD values of TAC and MDA respectively, p value of <0.05 was taken as significant. RESULT: Mean age and estimated glomerular filtration rate of subjects were 45 ±15 years and 6.3± 4.7mls/1.73m2 respectively. There was significant decrease in the mean TAC from 1232.2 ± 495.6 µmol Trolox equiv/ to 832.4 ± 325.7 µmol Trolox equiv/L post-dialysis (p< 0.001) while MDA values were similar before and after HD (11.8 ± 1.8 vs 11.8 ± 2.331)µmol/L (p> 0.05). There was no significant association between changes in antioxidant status following HD with blood flow rate, ultrafiltration volume nor dialyzer per size.
CONCLUSION: A session of HD in patients with CKD is associated with significant reduction of the total antioxidants capacity; and no effect on MDA levels. FUNDING: No external funding received.

Entities:  

Keywords:  antioxidants capacity; chronic kidney disease; hemodialysis; oxidative stress

Mesh:

Substances:

Year:  2018        PMID: 30013258      PMCID: PMC6026946          DOI: 10.4314/gmj.v52i1.6

Source DB:  PubMed          Journal:  Ghana Med J        ISSN: 0016-9560


  20 in total

1.  The effect of a membrane dialyzer during hemodialysis on the antioxidant status and lipid peroxidation of patients with end-stage renal disease.

Authors:  P S Ogunro; F A Olujombo; M O Ajala; T T Oshodi
Journal:  Saudi J Kidney Dis Transpl       Date:  2014-11

2.  Utility of predicted creatinine clearance using MDRD formula compared with other predictive formulas in Nigerian patients.

Authors:  Sanusi Abubakr Abefe; Arogundade Fatiu Abiola; Akintomide Anthony Olubunmi; Akinsola Adewale
Journal:  Saudi J Kidney Dis Transpl       Date:  2009-01

3.  Oxidative stress and antioxidant defenses in renal patients receiving regular haemodialysis.

Authors:  C Fiorillo; C Oliviero; G Rizzuti; C Nediani; A Pacini; P Nassi
Journal:  Clin Chem Lab Med       Date:  1998-03       Impact factor: 3.694

4.  Trace elements and lipid peroxidation in uremic patients on hemodialysis.

Authors:  T H Lin; J G Chen; J M Liaw; J G Juang
Journal:  Biol Trace Elem Res       Date:  1996-03       Impact factor: 3.738

5.  Effects of vitamin E-coated dialysis membranes on anemia, nutrition and dyslipidemia status in hemodialysis patients: a meta-analysis.

Authors:  Jing Huang; Bin Yi; Ai-Mei Li; Hao Zhang
Journal:  Ren Fail       Date:  2015-01-14       Impact factor: 2.606

6.  Effect of hemodialysis on total antioxidant status of chronic renal failure patients in government hospitals in Lagos Nigeria.

Authors:  M O Ajala; P S Ogunro; Alli Odun
Journal:  Niger J Clin Pract       Date:  2011 Apr-Jun       Impact factor: 0.968

7.  Role of cellulosic and noncellulosic membranes in hyperhomocysteinemia and oxidative stress.

Authors:  S Biasioli; R Schiavon; L Petrosino; L Cavallini; G Cavalcanti; E De Fanti; A Zambello; D Borin
Journal:  ASAIO J       Date:  2000 Sep-Oct       Impact factor: 2.872

8.  Assessment of plasma antioxidant status in hemodialysis patients.

Authors:  Mehri Kadkhodaee; Mohammad Hemmati; Maryam Zahmatkesh; Rana Ghaznavi; Fatemeh Mirershadi; Mitra Mahdavi-Mazde; Behjat Seifi
Journal:  Ther Apher Dial       Date:  2008-04       Impact factor: 1.762

9.  Advanced oxidation protein products as a novel marker of oxidative stress in uremia.

Authors:  V Witko-Sarsat; M Friedlander; C Capeillère-Blandin; T Nguyen-Khoa; A T Nguyen; J Zingraff; P Jungers; B Descamps-Latscha
Journal:  Kidney Int       Date:  1996-05       Impact factor: 10.612

10.  Worldwide, mortality risk is high soon after initiation of hemodialysis.

Authors:  Bruce M Robinson; Jinyao Zhang; Hal Morgenstern; Brian D Bradbury; Leslie J Ng; Keith P McCullough; Brenda W Gillespie; Raymond Hakim; Hugh Rayner; Joan Fort; Tadao Akizawa; Francesca Tentori; Ronald L Pisoni
Journal:  Kidney Int       Date:  2013-06-26       Impact factor: 10.612

View more
  3 in total

1.  Oxidative Status before and after Renal Replacement Therapy: Differences between Conventional High Flux Hemodialysis and on-Line Hemodiafiltration.

Authors:  José Alberto Navarro-García; Elena Rodríguez-Sánchez; Jennifer Aceves-Ripoll; Judith Abarca-Zabalía; Andrea Susmozas-Sánchez; Laura González Lafuente; Teresa Bada-Bosch; Eduardo Hernández; Evangelina Mérida-Herrero; Manuel Praga; Luis Miguel Ruilope; Gema Ruiz-Hurtado
Journal:  Nutrients       Date:  2019-11-17       Impact factor: 5.717

2.  The effects of vitamin E supplementation on malondialdehyde as a biomarker of oxidative stress in haemodialysis patients: a systematic review and meta-analysis.

Authors:  Peter Bergin; Aoife Leggett; Chris R Cardwell; Jayne V Woodside; Ammarin Thakkinstian; Alexander P Maxwell; Gareth J McKay
Journal:  BMC Nephrol       Date:  2021-04-09       Impact factor: 2.388

3.  The Influence of Sevelamer Hydrochloride and Calcium Carbonate on Markers of Inflammation and Oxidative Stress in Hemodialysis at Six Months of Follow-Up.

Authors:  Elodia Nataly Díaz-De la Cruz; José Ignacio Cerrillos-Gutiérrez; Andrés García-Sánchez; Carlos Gerardo Prado-Nevárez; Jorge Andrade-Sierra; Basilio Jalomo-Martínez; Adriana Banda-López; Enrique Rojas-Campos; Alejandra Guillermina Miranda-Díaz
Journal:  Front Med (Lausanne)       Date:  2021-11-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.